Skip to content

Clinical trials

Rectal Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Country / region: China Clear all

375 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20092
20106
20115
20126
20139
201412
20159
201621
201719
201820
201913
202026
202132
202237
202338
202436
202547
202632

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status132
Recruiting100
Completed76
Not yet recruiting28
Active, not recruiting25
Withdrawn6
Terminated3
Enrolling by invitation3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University31
Sixth Affiliated Hospital, Sun Yat-sen University30
Fudan University22
Chinese Academy of Medical Sciences13
Peking University Cancer Hospital & Institute11
West China Hospital11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences8
Sir Run Run Shaw Hospital8
Beijing Friendship Hospital7
Nanfang Hospital, Southern Medical University7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms375
Colonic Neoplasms29
Anastomotic Leak19
Colorectal Neoplasms19
Stomach Neoplasms11
Low Anterior Resection Syndrome8
Esophageal Neoplasms7
Lung Neoplasms7
Pathologic Complete Response7
Pancreatic Neoplasms6

Trials

Showing 51 to 75 of 375. Each trial links to its page on Pharma Observatory.

275 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.